Paper Details

  1. Home
  2. Paper Details

Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis.

Author: IngramC G, JohnstonR N, LeggeJ S, LightbodyI M

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Ipratropium bromide and salbutamol showed similar improvements in patients with bronchial asthma and chronic bronchitis. Combining both drugs doubled the FEV1 change.
Paper Details　
Original Abstract of the Article :
Eleven patients with bronchial asthma and 10 with chronic bronchitis were treated over four consecutive 3-day periods, firstly with aerosols either of ipratropium bromide (40 microgram four times a day) or of salbutamol (200 microgram four times daily) by random allocation, then the alternate drug, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0007-0971(78)90039-6

データ提供：米国国立医学図書館（NLM）

Exploring the Efficacy of Ipratropium Bromide, Salbutamol, and Prednisolone in Bronchial Asthma and Chronic Bronchitis

The quest for effective treatments for respiratory conditions like bronchial asthma and chronic bronchitis is akin to traversing a desert with limited resources and unpredictable weather. This study, like a camel caravan equipped with various tools for survival, investigates the efficacy of ipratropium bromide, salbutamol, and prednisolone in managing these conditions. The researchers employed a crossover design, a clever approach akin to navigating a changing landscape, to compare the effects of these medications on lung function and symptom severity.

Comparing the Efficacy of Respiratory Medications

This study, like a camel caravan discovering a new oasis, highlights the effectiveness of ipratropium bromide and salbutamol in improving lung function and symptoms in patients with bronchial asthma and chronic bronchitis. The study also suggests that the combination of both drugs, like merging two caravans for strength and efficiency, provides a more pronounced benefit.

Managing Respiratory Conditions Effectively

Managing respiratory conditions, like navigating a shifting sand dune landscape, requires a nuanced approach. This study provides valuable insights into the efficacy of various medications and emphasizes the importance of individualized treatment plans tailored to the specific needs of each patient.

Dr.Camel's Conclusion

This study, much like a camel caravan navigating a vast and challenging desert, offers valuable insights into the management of bronchial asthma and chronic bronchitis. The findings suggest that ipratropium bromide, salbutamol, and prednisolone, like a collection of essential tools for survival, can play a significant role in improving lung function and relieving symptoms. As we continue to explore this complex terrain, this study provides a roadmap for optimizing treatment strategies and ensuring that patients receive the most effective and personalized care possible.

Date :
  1. Date Completed 1978-12-20
  2. Date Revised 2019-10-21
Further Info :

Pubmed ID

151547

DOI: Digital Object Identifier

10.1016/0007-0971(78)90039-6

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.